Comparing Amyotrophic lateral sclerosis (ALS) patient characteristics from the National ALS Registry and the Massachusetts ALS Registry, data through 2015.

Raymond, Jaime; Punjani, Reshma; Larson, Theodore; Berry, James D; Horton, D Kevin; Mehta, Paul

Raymond, Jaime; Punjani, Reshma; Larson, Theodore; Berry, James D; Horton, D Kevin; Mehta, Paul.

Afiliação

Raymond J; Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA, USA and.
Punjani R; Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA, USA and.
Larson T; Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA, USA and.
Berry JD; Sean M Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, MA, USA.
Horton DK; Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA, USA and.
Mehta P; Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA, USA and.

Amyotroph Lateral Scler Frontotemporal Degener ; : 1-8, 2023 Aug 04.

Article em En | MEDLINE | ID: mdl-37539949

Palavras-chave

ALS; epidemiology; patient-ascertainment; registry

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google